Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Vimal Mehta currently holds 1,532 shares of BioXcel Therapeutics, Inc. (BTAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vimal Mehta has been a net seller of BTAI stock. They have purchased $89.3K and sold $18.4M worth of shares.
Vimal Mehta's most recent insider trade was on Mar 15, 2026, when they sold 219 shares at $0.00 per share.
Vimal Mehta serves as Executive at BioXcel Therapeutics, Inc. (BTAI). They have executed 88 insider transactions totaling $18.5M over their tenure at the company.
Vimal Mehta holds the position of Executive at BioXcel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Vimal Mehta has shown a selling trading pattern, with $89.3K in total purchases and $18.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Vimal Mehta was on Mar 21, 2023, when they sold $573.3K worth of BTAI shares. This transaction involved 29,100 shares at $19.70 per share.
Vimal Mehta currently owns 1,532 shares of BioXcel Therapeutics, Inc. (BTAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Vimal Mehta's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Vimal Mehta has 88 Form 4 filings on record as an insider at BioXcel Therapeutics, Inc..
Set alerts for Vimal Mehta and 40,000+ other insiders.